Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS4837390 A
Publication typeGrant
Application numberUS 06/493,600
Publication dateJun 6, 1989
Filing dateMay 11, 1983
Priority dateMay 11, 1983
Fee statusLapsed
Also published asCA1223821A1, EP0125847A2, EP0125847A3
Publication number06493600, 493600, US 4837390 A, US 4837390A, US-A-4837390, US4837390 A, US4837390A
InventorsRaymond P. Reneau
Original AssigneeKeyes Offshore, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Storage in perfusate nutrient liquid
US 4837390 A
Abstract
An apparatus (A) and method for preserving living organs extracorporeally in vessel (V) having a hyperbaric chamber (C) therein. The organ (O) stored in chamber (C) is provided with perfusate (P) from a reservoir (R) which is open to the atmosphere and freely accessible for the user who may thereby change or add constituents to the perfusate (P) without depressurizing the apparatus (A).
Images(1)
Previous page
Next page
Claims(7)
I claim:
1. A method for preserving living organs extracorporeally utilizing a perfusate, including the steps of:
storing the organ in a chamber formed in a vessel having a hyperbaric atmosphere;
maintaining a supply of the perfusate in a reservoir under ambient pressure; and,
supplying the organ in the chamber with perfusate from the reservoir.
2. The method of claim 1, further including the step of:
changing the constituent components of the perfusate in the reservoir without depressurizing the organ within the chamber at hyperbaric atmosphere.
3. The method of claim 1, wherein said supplying includes the steps of:
pumping perfusate at ambient pressure from said reservoir through a conduit in fluid communication with said reservoir and said hyperbaric atmosphere;
maintaining the pressure differential between said reservoir and said hyperbaric atmosphere.
4. The method of claim 3, further including the steps of:
returning effluent perfusate from said hyperbaric chamber to said reservoir.
5. The method of claim 4, further including the steps of:
filtering the effluent perfusate before returning the effluent perfusate to said reservoir.
6. The method of claim 1, further including the step of:
maintaining the temperature of the organ within a temperature range of -10 C. to 40 C.
7. The method of claim 1, wherein said storing includes maintaining a hyperbaric atmosphere in the chamber of at least three bars.
Description
FIELD OF THE INVENTION

This invention relates to apparatus and methods for the preservation of living organs extracorporeally such as is required pending transplantation of organs from one being to another.

BACKGROUND OF THE INVENTION

Organ transplantation and preservation is a field of increasing importance due to the advances in the medical arts and sciences related to organ transplants which have made it possible to transplant a variety of living tissues and organs. It is generally recognized in the art that preservation of living tissue is most effective if the tissue is immersed in a perfusate, nutrient liquid, and is maintained in a refrigerated, hyperbaric environment.

It has been found to be desirable for effective preservation to provide a chamber wherein the temperature is less than 37 C. and the pressure is from two to fifteen bars above ambient atmospheric pressure. Furthermore, it is desirable to perfuse the organ with plasma or other similar fluid which provides the necessary nutrient and oxygen to the organ. This perfusate may also contain additives such as hormones, steroids, penicillin, antibiotics or the like to treat specific conditions found in the organ being preserved. Prior art systems generally provided a hyperbaric chamber for storing the organ under the prescribed environmental conditions and a closed, pressurized reservoir and conduit system as a source of perfusate.

When an organ is being preserved in this manner, the attending physician may require that the perfusate be modified as, for example, to include additives or change the basic composition of the fluid. In the past, the perfusate and the preservation chamber were maintained at equilibrium pressures, either both under hyperbaric conditions or both at ambient pressure. Since it is desirable to provide a hyperbaric environment for the organ, prior preservation systems were closed, pressurized systems, wherein both the perfusate and the preservation chamber were maintained at elevated pressures. In these past systems, it is generally necessary to depressurize the entire system, including the organ preservation chamber, in order to change or modify the perfusate.

It is well known that depressurization of the organ must be done carefully to avoid creating gassy embolisms in the organ tissues. These past systems all suffered from the highly undesirable requirement of having to follow carefully prescribed and time consuming procedures for depressurizing the preservation system each time it was necessary or desired to modify or test the perfusate.

SUMMARY OF THE INVENTION

In contrast to the foregoing, the present invention provides a new hyperbaric organ preservation system and method wherein the perfusate reservoir is maintained at ambient pressure, even though the organ preservation chamber is at the desirable elevated pressure. In the apparatus of the present invention perfusate is maintained in an ambient pressure reservoir which allows the attendant to test, modify, add or delete perfusate without effecting the pressure environment of the organ and thus avoids the need to carefully depressurize the system.

BRIEF DESCRIPTION OF THE DRAWING

FIG. 1 is a schematic drawing of an organ preservation apparatus of the present invention.

DESCRIPTION OF THE PREFERRED EMBODIMENT

Referring to FIG. 1, the letter A designates generally an organ preserving apparatus according to the present invention. The letter O designates a living organ such as a kidney, liver or a heart which is to be preserved in the apparatus A. Apparatus A includes an organ preservation vessel V formed having a hyperbaric chamber C therein for storing the organ O in a controlled pressurized environment, a perfusate reservoir R, and a perfusate supply system S. The apparatus A is shown in association with peripheral support equipment including a perfusate refrigeration system 10, a regulated high pressure gas supply 12, and an organ condition monitor 14. The various components of apparatus A are shown schematically in FIG. 1 and are not drawn to scale nor with particular structural detail since the structural details of the individual components are matters known to those of ordinary skill in the art. Furthermore, as is also known to those of ordinary skill in the art and hence not specified hereafter, all components of apparatus A which come in direct or indirect contact with the organ O are constructed of suitable biomaterial so that the environment for the organ O will not be contaminated.

The organ O is stored in the hyperbaric chamber C of the organ preservation vessel V and is immersed in a bath of perfusate P. Preferably, chamber C is maintained at a pressure of at least three (3) bars which enhances preservation of the organ O. Perfusate P is life sustaining artificial blood plasma or similar liquid which is circulated from reservoir R to chamber C via perfusate supply system S. The organ preservation vessel V is a high pressure vessel having a sealable door 16 to provide access to the chamber C so that the organ O may be placed therein. The vessel V may be constructed in any suitable conventional manner to provide a pressure tight chamber C capable of withstanding interior pressures up to fifteen (15) bars. While not illustrated, it is also desirable to provide the vessel V with at least one transparent window so that organ O may be observed without opening the chamber C. Regulated gas supply 12 may be any suitable apparatus for providing a regulated source of high pressure gas, such as oxygen, as is known in the art. In the preferred embodiment, supply 12 includes a source of high pressure gas, such as canister 18, a regulator 20, gas supply conduit 22 and gas vent conduit 24. Regulator 20 includes conventional pressure gauges and control mechanisms to enable the operator to set, adjust and monitor the gas pressure in chamber C of the vessel V.

Reservoir R is a fluid receptacle for perfusate P and may be constructed of any suitable material and in the particular shape or configuration as desired. In the preferred embodiment, reservoir R is constructed with material having a low thermal conductivity to facilitate the refrigeration of perfusate P. Perfusate refrigeration unit 10 is a conventional regulated liquid refrigeration apparatus which uses a coolant such as freon circulated through heat exchanger 26 to effect and control the temperature of perfusate P in reservoir R. Refrigeration unit 10 includes a temperature sensing element 27 to sense the temperature of perfusate P and a suitable thermostat (not illustrated) to form a temperature control signal to maintain the temperature of perfusate P within the prescribed range. Refrigeration unit 10 may be any suitable refrigeration system such as are known in the art which is capable of maintaining the temperature of perfusate P in the range of -10 C. to 40 C. at ambient pressure. If desired, the heat exchanger 26 of refrigeration unit 10 could be mounted within chamber C rather than reservoir R, since the object and function of refrigeration unit 10 is to maintain the temperature of the organ O indirectly by cooling the perfusate P. Thus, the temperature sensing element 27 could alternatively be mounted within the chamber C or within/adjacent to the organ O. Reservoir R is provided with a perfusate outlet 28 and a perfusate return inlet 29 suitably located below the normal perfusate level to permit perfusate to circulate from the reservoir R to chamber C within the vessel V ahd back to reservoir R via the perfusate supply system S.

Supply system S includes a pump 30, a delivery conduit 32, a check valve 34, a return conduit 36, and a back pressure regulator 38. Pump 30 provides fluid pressure to circulate perfusate P from reservoir R to chamber C and may be any suitable pump capable of providing sufficient fluid pressure to deliver perfusate to chamber C when chamber C is pressurized from two (2) to fifteen (15) bars above the ambient pressure of the reservoir R. In the preferred embodiment, pump P provides a steady flow of perfusate P to chamber C, but other types of pumps could be used to provide pulsating flow of perfusate if desired. Selection of the particular type of pump 30 to be used is dependent upon the volume of perfusate P that is necessary to circulate via conduit 32, as well as other factors that are known to those of ordinary skill in the art and thus need not be described herein.

Conduit 32, which may be any suitable conduit for transferring perfusate P, is in fluid communication with reservoir R via outlet 28 and with chamber C of the vessel V via check valve 34 and inlet 37. Check valve 34 and inlet 38 allow unidirectional flow of perfusate P from conduit 32 into chamber C in response to fluid pressure provided by pump 30. Check valve 34 prevents perfusate flow from chamber C via inlet 38 and thus isolates hyperbaric chamber C from the ambient pressure reservoir R.

Back pressure regulator 38 is a conventional pressure regulator and relief valve mechanism which senses the pressure in chamber C through conduit 50 which is in communication with the gas vent conduit 24 and opens to maintain a prescribed fluid pressure differential between chamber C and reservoir R. Regulator 38 permits return circulation of effluent perfusate P to reservoir R via outlet 40 in chamber C, return conduit 36 and inlet 29 in reservoir R. If desired, a filter unit or filtration means 39 may be included interposed between return conduit 36 and reservoir R to remove organ by-products and impurities from the effluent perfusate P. The back pressure regulator 38 and return conduit 36 form the perfusate return means of the present invention. Alternatively, the perfusate return means may include fixed or variable in-line orifices (not shown) which may be mounted in flow communication with conduits 32, 36, respectively, for providing back pressure control, eliminating the need for the back pressure regulator 38 and conduit 50 if desired. Filter unit 39 located in conduit 36 is illustrated schematically in FIG. 1, and may be any suitable plasma filter as are commonly available. Filter unit 39 may alternatively be positioned in conduit 32. Furthermore, flow meters 62, 64 are positioned in fluid communication with conduits 36, 32, respectively, for determining the volumetric amount of perfusate (hence the quantity of additives such as vitamins, minerals, antibiotics and all types of metabolic additives) available to organ O.

If desired, apparatus A may also include peripheral instruments for monitoring the condition of the organ. Monitor 14 is a schematic illustration of such conventional instrumentation and includes a multiple element cable 42 for providing the monitor 14 with electrical signals indicative of the condition of organ O. Cable 42 is shown mounted to vessel V via a sealed mounting 44 which permits access to the chamber C without pressure loss. Cable 42 terminates at probe 46 which is a schematic representation of an electrical sensing instrument as is commonly available, and which provide analogue or digital electrical signals indicative of such organ environmental conditions as the organ temperature, transcutaneous gas pressure, and the tissue oxygen partial pressure.

Thus apparatus A provides a controlled hyperbaric environment for oxygen preservation wherein the organ O is bathed in perfusate P provided from an ambient pressure reservoir R. In use, the organ O is placed in the chamber C of vessel V in a bath of perfusate P provided from reservoir R. Chamber C of vessel V is then pressurized to provide a prescribed, hyperbaric environment for the organ O via regulated oxygen supply 12. Regulator 12 maintains the oxygen pressure inside chamber C at the prescribed level. It has been discovered that an oxygen pressure of at least three (3) bars significantly improves preservation. Perfusate P is circulated under pressure from reservoir R to vessel V into the chamber C to provide oxygen, nutrients and treatment to the organ O as is required. The temperature of the organ O is controlled indirectly by controlling the temperature of perfusate P. Other conditions of the organ O may be monitored via monitor 14.

When the attending physician determines that it is necessary or desirable to add to or modify the constituents of the perfusate P, since reservoir R is maintained at ambient pressure, the attendant need not depressurize any part of apparatus A and in particular need not depressurize the chamber C. The apparatus A is thus a significant advance in the art which eliminates the need for time consuming depressurizing procedures and avoids difficulties such as the development of gassy embolisms when a modification of the perfusate P is desired.

The foregoing disclosure and description of the invention are illustrative and explanatory thereof, and various changes in the size, shape and materials, as well as in the details of the illustrated construction may be made without departing from the spirit of the invention.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US3406531 *Aug 25, 1964Oct 22, 1968Emil S. SwensonApparatus for maintaining organs in a completely viable state
US3545221 *May 22, 1967Dec 8, 1970Swenko Research & Dev IncApparatus for maintaining organs in vitro in a completely viable state
US3654085 *Nov 17, 1969Apr 4, 1972Aga AbStorage device for organ transplants
US3772153 *Feb 25, 1971Nov 13, 1973Air LiquideApparatus for the preservation of animal or human organs in living condition
US3827251 *Jul 2, 1973Aug 6, 1974W KoskiApparatus for cooling a living organ
US3843455 *Sep 13, 1972Oct 22, 1974M BierApparatus and technique for preservation of isolated organs through perfusion
US3881990 *Sep 26, 1973May 6, 1975Waters Instr IncMethod of transporting and storing organs while retaining the organs in a viable condition
US3892628 *Dec 19, 1972Jul 1, 1975Baxter Laboratories IncPreservation of organs
US3914954 *Sep 1, 1972Oct 28, 1975Roland Karl DoerigProcedure for conservation of living organs and apparatus for the execution of this procedure
US3995444 *Nov 8, 1974Dec 7, 1976American Hospital Supply CorporationOrgan perfusion system
US4186565 *May 19, 1978Feb 5, 1980Henry Ford HospitalPerfusion system for organ preservation
Non-Patent Citations
Reference
1 *Perry, Chemical Engineers Handbook, New York, McGraw Hill, 1973, pp. 6 56 to 6 57.
2Perry, Chemical Engineers' Handbook, New York, McGraw Hill, 1973, pp. 6-56 to 6-57.
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US5110721 *Feb 10, 1989May 5, 1992The Research Foundation Of State University Of New YorkMethod for hypothermic organ protection during organ retrieval
US5217860 *Jul 8, 1991Jun 8, 1993The American National Red CrossMethod for preserving organs for transplantation by vitrification
US5326706 *Aug 31, 1990Jul 5, 1994Research Foundation Of State University Of New YorkHomeostatic organ preservation system
US5328821 *Dec 12, 1991Jul 12, 1994Robyn FisherGlucose
US5356771 *Mar 11, 1993Oct 18, 1994Board Of Regents, The University Of Texas SystemCombined perfusion and oxygenation organ preservation apparatus
US5362622 *Mar 11, 1993Nov 8, 1994Board Of Regents, The University Of Texas SystemCombined perfusion and oxygenation apparatus
US5385821 *Jul 19, 1994Jan 31, 1995Board Of Regents, The University Of Texas SystemMethod for hypothermic preservation of living tissue
US5472876 *Jan 19, 1995Dec 5, 1995The American National Red CrossFor introducing and removing vitrifiable concentrations of cryoprotective agents into and from isolated organs for preservation and use
US5622819 *Mar 28, 1995Apr 22, 1997Kinetic Biosystems, Inc.Centrifugal fermentation process
US5723282 *Aug 18, 1994Mar 3, 1998The American National Red CrossMethod of preparing organs for vitrification
US5821045 *May 31, 1995Oct 13, 1998The American National Red CrossMethods for removal of cryoprotectant from organs prior to transplantation
US5821116 *Jan 16, 1997Oct 13, 1998Kinetic Biosystems, Inc.Centrifugal fermentation process
US5856081 *Jun 7, 1995Jan 5, 1999The American National Red CrossComputer controlled cryoprotectant perfusion apparatus
US5962214 *Feb 27, 1998Oct 5, 1999The United States Of America As Represented By The American National Red CrossMethod of preparing tissues and cells for vitrification
US6133019 *Jul 13, 1998Oct 17, 2000Kinetic Biosystems, Inc.Centrifugal fermentation process
US6187529Apr 28, 1998Feb 13, 2001The American National Red CrossControlled heating; osmotic buffer
US6214617Dec 31, 1998Apr 10, 2001Kinetic Biosystems, Inc.Centrifugal fermentation process
US6660509May 21, 1999Dec 9, 2003Kinetic Biosystems, Inc.Culture methods and devices in which living cells or subcellular biocatalysts are immobilized by the opposition of forces; isolation of metals from ores and removal of gases.
US6673594Aug 25, 2000Jan 6, 2004Organ Recovery SystemsPortable hermetically-sealed housing configured to be received by organ perfusion device
US6703217Jan 31, 2001Mar 9, 2004Kinetic Biosystems, Inc.Methods and devices for remediation and fermentation
US6794182 *Mar 12, 2001Sep 21, 2004E. George Wolf, Jr.Hyperbaric oxygen organ preservation system (HOOPS)
US6916652May 22, 2002Jul 12, 2005Kinetic Biosystems, Inc.Biocatalyst chamber encapsulation system for bioremediation and fermentation
US7678563Apr 2, 2004Mar 16, 2010Organ Recovery Systems, Inc.Organ perfusion device for monitoring, sustaining and/or restoring viability of organs and for the preserve of organs for storage and/or transport
US7691622Apr 2, 2004Apr 6, 2010Lifeline Scientific, Inc.Method and apparatus for transferring heat to or from an organ or tissue container
US7749693Feb 2, 2004Jul 6, 2010Lifeline Scientific, Inc.Perfusing organ with immunotoxin and monitoring effects; sustaining and/or restoring viability of organs and preserving organs for storage and/or transport
US7824848Jul 11, 2003Nov 2, 2010Lifeline Scientific, Inc.Organ perfusion device for sustaining, restoring viability, storage, transport and preservation of tissues
US7998725Apr 2, 2004Aug 16, 2011Organ Recovery SystemsMethod and apparatus for holding a plurality of tubes connectible to an organ or tissue container
US8097449Feb 16, 2010Jan 17, 2012Organ Recovery SystemsMethod and apparatus for transferring heat to or from an organ or tissue container
US8128740Apr 2, 2004Mar 6, 2012Organ Recovery Systems, Inc.Device for separating gas from a liquid path
US8268547Oct 25, 2005Sep 18, 2012Lifeline Scientific, Inc.Method of transporting and storing a kidney
US8268612Aug 10, 2011Sep 18, 2012Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8318415Oct 22, 2010Nov 27, 2012Lifeline Scientific, Inc.Method of determining transport and/or storage parameters for maintaining viability of an organ
US8323954Mar 29, 2011Dec 4, 2012Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8349551Nov 5, 2010Jan 8, 2013Lifeline Scientific, Inc.Method for controlling perfusion of an organ
US8361091Aug 25, 2003Jan 29, 2013Organ Recovery Systems, Inc.Cannulas, cannula mount assemblies, and clamping methods using such cannulas and cannula mount assemblies
US8389271Dec 31, 2009Mar 5, 2013Organ Recovery Systems, Inc.Method and apparatus for controlling air pressure in an organ or tissue container
US8420381Nov 5, 2010Apr 16, 2013Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8431385Jan 21, 2011Apr 30, 2013Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8445260Aug 10, 2011May 21, 2013Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8609400May 12, 2010Dec 17, 2013Lifeline Scientific, Inc.Apparatus and method for maintaining and/or restoring viability of organs
US8828034Apr 29, 2011Sep 9, 2014Lifeline Scientific, Inc.Cannula
DE19527734A1 *Jul 28, 1995Jan 30, 1997Hubert VerhaagVerfahren und Vorrichtung zur Konservierung von Geweben und Organen, insbesondere von Transplantationsgeweben und -organen
WO2001003505A1 *Jul 7, 2000Jan 18, 2001Bernd KlemmMethod and device for preserving animal and human preparations as well as microorganisms and for prolonging the viability of organs and body parts to be transplanted
WO2003026419A1 *Sep 27, 2002Apr 3, 2003Edward F M D GoodA simple, fully transportable device for maintaining an excised heart in optimum condition for transplantation
Classifications
U.S. Classification435/1.2
International ClassificationA01N1/02, A01N1/00
Cooperative ClassificationA01N1/02, A01N1/0247
European ClassificationA01N1/02, A01N1/02M2P
Legal Events
DateCodeEventDescription
Oct 16, 1998ASAssignment
Owner name: PROTEUS HYPERBARIC SYSTEMS, INC., CALIFORNIA
Free format text: CHANGE OF NAME;ASSIGNOR:RENEAU, INC.;REEL/FRAME:009516/0202
Effective date: 19941202
Aug 24, 1993FPExpired due to failure to pay maintenance fee
Effective date: 19930606
Jun 6, 1993LAPSLapse for failure to pay maintenance fees
Jan 6, 1993REMIMaintenance fee reminder mailed
Mar 12, 1990ASAssignment
Owner name: RENEAU, INC., A CORP. OF TX
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:KEYES OFFSHORE, INC.;REEL/FRAME:005251/0509
Effective date: 19900216
Oct 25, 1984ASAssignment
Owner name: KEYES OFFSHORE, INC., A TX CORP.
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:RENEAU, RAYMOND P.;REEL/FRAME:004326/0419
Effective date: 19841016
Owner name: RENEAU, RAYMOND PAUL,
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:RENEAU, INC;REEL/FRAME:004326/0417
Effective date: 19841015
May 11, 1983ASAssignment
Owner name: RENEAU, INC., A CORP. OF TX
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:RENEAU, RAYMOND P.;REEL/FRAME:004129/0236
Effective date: 19830505
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:RENEAU, RAYMOND P.;REEL/FRAME:004129/0236
Owner name: RENEAU, INC., TEXAS